Pregnancy after uterine arterial embolization by Bonduki, Cláudio Emilio et al.
CLINICAL SCIENCE
Pregnancy after uterine arterial embolization
Cla´udio E. Bonduki, Paulo C. Feldner, Jr., Juliana da Silva, Rodrigo A. Castro, Marair G. F. Sartori,
Manoel J. B. C. Gira˜o
Department of Gynecology, Federal University of Sa˜o Paulo, Sa˜o Paulo, SP, Brazil.
OBJECTIVE: To evaluate pregnancy outcomes, complications and neonatal outcomes in women who had previously
undergone uterine arterial embolization.
METHODS: A retrospective study of 187 patients treated with uterine arterial embolization for symptomatic uterine
fibroids between 2005-2008 was performed. Uterine arterial embolization was performed using polyvinyl alcohol
particles (500-900 mm in diameter). Pregnancies were identified using screening questionnaires and the study
database.
RESULTS: There were 15 spontaneous pregnancies. Of these, 12.5% were miscarriages (n= 2), and 87.5% were
successful live births (n = 14). The gestation time for the pregnancies with successful live births ranged from 36 to
39.2 weeks. The mean time between embolization and conception was 23.8 months (range, 5–54). One of the
pregnancies resulted in twins. The newborn weights (n = 14) ranged from 2.260 to 3.605 kg (mean, 3.072 kg). One
(7.1%) was considered to have a low birth weight (2.260 kg). There were two cases of placenta accreta (12.5%,
treated with hysterectomy in one case [6.3%]), one case of premature rupture of the membranes (PRM) (6.3%), and
one case of preeclampsia (6.3%). All of the patients were delivered via Cesarean section.
CONCLUSION: In this study, there was an increased risk of Cesarean delivery. There were no other major obstetric
risks, suggesting that pregnancy after uterine arterial embolization is possible without significant morbidity or
mortality.
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INTRODUCTION
Uterine artery embolization (UAE), which has been
described in numerous reports since 1995, is a recognized
treatment for symptomatic uterine fibroids.1 The technical goal
is to deliver particulate material (typically polyvinyl alcohol
[PVA] particles or gelatin-coated polymer microspheres) into
both uterine arteries to induce ischemic alterations to the
myomas without causing permanent damage to the uterus.2-4
Despite many studies that have assessed uterine myomas
and infertility, the mechanism underlying their detrimental
reproductive effects remains to be determined. Similarly,
studies evaluating the effects that UAE may have on
subsequent fertility and pregnancy have yielded conflicting
and limited data.5,6
Although there are valid concerns regarding the effects of
UAE on women who wish to retain fertility, pregnancy after
this procedure is well documented. Pregnancy after UAE has
been described in case reports, a review article,7 retrospective
series,8-10 and a retrospective cohort study that comparedUAE
and laparoscopic myomectomy.11
A retrospective analysis by Walker and McDowell found
56 completed pregnancies in a series of 1200 patients who
underwent UAE. This cohort included 108 women who
attempted pregnancy, and 30.5% of these pregnancies were
categorized as successful. The authors noted that 14 of the
women with successful pregnancies had failed myomec-
tomies and had been offered a hysterectomy as their only
option before undergoing UAE.12
The main purpose of this study is to present the
pregnancy outcomes and complication rates of UAE.
Population
Between July 2005 and December 2008, we performed 187
consecutive UAEs. Fifteen pregnant patients from this
population are included in this review.
All of the patients provided informed consent to
participate in this study, and the Local Ethics Committee
approved the related protocol. This study was supported by
the Department of Gynecology and the Department of
Image Diagnosis of the Federal University of Sa˜o Paulo.
There was no external sponsor.
The clinical diagnosis of myoma was confirmed by
ultrasonography. The indications for UAE were as
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follows: menorrhagia subjectively reported by the patient
as increased or prolonged menstrual blood loss that
caused dysfunction in daily life, pelvic pain, compressive
symptoms in the urinary/gastrointestinal tract, and
infertility related to fibroids. All of the patients wanted
to maintain their fertility and desired a conservative
treatment.
A patient’s desire to preserve fertility was not an
exclusion criterion. The pregnancies were documented by
interviews performed during follow-up.
The exclusion criteria for UAE were as follows: subserosal
and submucosal fibroids, pelvic infections, gynecologic
malignancy, an undiagnosed pelvic mass outside of the
uterus, unexplained abnormal menstrual bleeding, coagulo-
pathy, a history of pelvic irradiation, a FSH level . 40 IU/L,
and adenomyosis indicated by magnetic resonance imaging.
Patients with intramural fibroids with submucosal compo-
nents were also excluded.
The patients were treated with prophylactic antibiotics
(1 g of oral azithromycin on the day before the procedure
and 2 g of intravenous cefalotin about sixty minutes before
the procedure). The analgesia was epidural or intradural.
Selective catheterization of the uterine arteries was per-
formed bilaterally and guided by angiography. A 4-F or 5-F
catheter was introduced into the right femoral artery and
advanced over the aortic bifurcation and into the contral-
ateral internal iliac artery to identify the origin of the uterine
artery. UAE was performed with PVA particles (500-900 mm
in diameter). The material was continually injected until the
cessation of circulation was confirmed via angiography.
This procedure was performed on both uterine arteries. The
patient preparation, anesthesia and analgesia details, pro-
cedure information, and discharge information were
recorded.
RESULTS
A retrospective study of 187 women treated over a period
of 3.5 years was performed. The mean patient age was 34.3
years (range, 26-40 years). Of the 187 women who under-
went UAE, 75 had been seeking to become pregnant at some
point, and 15 of these 75 women became pregnant at least
once. However, their outcomes were variable.
The characteristics of the pregnancies are shown in
Table 1. In the 187 women who underwent UAE, there
were 15 spontaneous conceptions. The mean time between
embolization and conception was 23.8 months (range, 5–54
months). One pregnancy occurred in the first year, 8
occurred in the second year, and 6 occurred in the third
year following embolization.
These 15 pregnancies resulted in 14 live births, with 2
early miscarriages. The pregnancies lasted at least 36 weeks,
with only one pre-term delivery. One of the pregnancies
resulted in twins.
All 13 pregnancies were delivered by Cesarean section
due to the obstetricians fearing complications from the
pregnancies uterine artery embolizations. The indications
for a Cesarean section were as follows: the decision of the
attending obstetrician, risk avoidance in patients who had
long and painful histories of trying to conceive, an older
primiparous patient with preeclampsia, a history of prior
myomectomy, a macrosomic fetus, and a labor induction
that had previous failed.
The weights of the newborns ranged from 2260-3605 g.
No cases exhibited chronic or acute fetal distress, and there
was no impairment of vitality.
Abnormal placental implantation (placenta accreta)
occurred in two patients, and one case terminated in a
puerperal hysterectomy. There was one case of premature
membrane rupture at 29 weeks, which lasted until a
Cesarean section delivery at 36 weeks.
Comment
The efficacy of UAE has been published in the Cochrane
Database. This meta-analysis documented that UAE results
in a shorter hospitalization time and a reduction in blood
loss (85% compared to pretreatment) and uterine size (30-
49% compared to pretreatment).4 However, maintenance of
fertility after UAE is still controversial. Until now, the
impact of this treatment on fertility has not been estab-
lished.13,14
Theoretically, UAE may contribute to difficulties during
embryonic implantation or the maintenance of pregnancy
by decreasing the vascularity of the uterine myometrium
and endometrium. In fact, embolization particles have been
identified in structures adjacent to leiomyomas (e.g.,
myometrium, parametrium, and mesovarium) after UAE.15
Data are insufficient to conclude that UAE is a safe option
for women who wish to retain their fertility.16 Normal
pregnancy and delivery can be achieved after UAE for
uterine leiomyomata, as has been shown for postpartum
hemorrhages. Comparing pregnancy outcomes after UAE
with leiomyomata is complicated by the size and location of
the myomata and the fact that non-subserosal leiomyomas
reduce fertility.17 UAE pregnancy outcomes are reduced
most severely when submucosal myomas cause endometrial
distortion. Reports have not documented the number of
women who have attempted pregnancy after embolization;
therefore, cycle conception and fecundity rates cannot be
calculated.18 In this series, we do not associate complication
rates with their direct impacts on fertility, such as ovarian
insufficiency.
One study reported 29 pregnancies in 671 women who
had undergone UAE. The authors reported that 27% of
these pregnancies ended in miscarriage, with two termina-
tions and one ectopic pregnancy. Of the 16 deliveries that
occurred after 24 weeks, first- and second-trimester bleed-
ing occurred in 40% and 33% of these deliveries, respec-
tively, and 25% had preterm deliveries. The Cesarean
section rate was 88%. Thirteen percent of the women had
spontaneous preterm membrane ruptures, and the rate of
primary postpartum hemorrhage was 20%. The mean birth
weight of the term babies was 3.39 kg, and none required
admission into the neonatal intensive care unit. There was
one case of fetal growth restriction.19
Another retrospective analysis was undertaken to evalu-
ate the incidence and outcomes of pregnancies after UAE for
symptomatic uterine fibroids. Fifty-six completed pregnan-
cies were identified in approximately 1200 women. Of the
108 patients that were attempting to become pregnant, 33
became pregnant, and 58.9% of the pregnancies had
successful outcomes. Premature delivery occurred in
18.2% of these cases, and 30.4% of the pregnancies
miscarried. Of the 33 deliveries, 72.7% were delivered by
Cesarean section. There were 18.2% cases of postpartum
hemorrhage. Compared with the general obstetric popula-
tion, the authors found a significant increase in Cesarean
Pregnancy after uterine arterial embolization
Bonduki CE et al.
CLINICS 2011;66(5):807-810
808
section deliveries and increases in preterm deliveries,
postpartum hemorrhages, and miscarriage that were asso-
ciated with lower pregnancy rates.12
Instances of placental alterations after UAE, such as
placenta previa, placenta accreta, and abruptio placentae,
have been reported in the literature.10,19 There were two
cases of abnormal placental implantation in our patient
series.
The frequency of spontaneous abortion is known to
increase with maternal age, ranging from a rate of 18% in
the late 30s to 34% in the early 40s in the general population.
The 13.3% spontaneous abortion rate in our series does not
appear to be higher than the general population rates.
Relatively high rates (41.2%) of early miscarriages after
laparoscopic uterine artery coagulation were observed by
Chen et al.20
Only one of the 15 live newborns in our study had a low
birth weight, and the gestation time reached 36 weeks for all
of the mothers. In contrast, preterm delivery rates ranging
from 10% to 42.8% have been recorded in other studies.10,19
A high rate of pregnancy complications was not observed
in our study, probably because a limited embolization (of
only the tumor vessels) was performed. However, the
degree of dominant fibroid ischemia after UAE, which is
very important, was over 50% in every patient.
This study is a report on pregnancies following emboliza-
tion for uterine fibroids. Although the sample size is small,
when using a relatively new procedure such as UAE, it is
important to identify complications that could make
pregnancy more hazardous. When interpreting the findings
from this study, it must be remembered that this cohort is
not typical of the general obstetric population.
The number of deliveries in this study was too small to
allow us to make any recommendations on delivery
management or draw conclusions. However, the pregnancy
rate reported here adds to the growing number of reported
cases of pregnancy after uterine artery embolization as a
treatment for fibroids and suggests that it may be appro-
priate to reconsider the contraindication for this procedure
in younger women who wish to preserve their fertility.
Randomized controlled trials comparing myomectomy and
embolization in a younger population desiring pregnancy
are necessary.
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